The impact of the ketogenic diet on the health of patients with Alzheimer’s disease
DOI:
https://doi.org/10.12775/JEHS.2024.52.007Keywords
Health, Diet, ketogenic diet, Alzheimer’s disease, Diet in neurological diseases, Nutrition, Ketone bodiesAbstract
INTRODUCTION:
Diet is an integral element of every individual's health. Its impact on the functioning of the human body has fascinated scientists for years. One of the diets that alters the mechanism of the body's functioning is the ketogenic diet. The impact of the ketogenic diet on various disorders is still under investigation. It is known to have shown numerous benefits in reducing epileptic seizures, but its impact on other neurological disorders is less known. In this literature review, the efficacy of ketogenic therapies was assessed in Alzheimer's disease.
AIM OF STUDY:
Review of the current literature (since 2018) on the effects of implementing a ketogenic diet in patients with Alzheimer's disease.
MATERIALS AND METHODS:
The review was based on data gathered from the PubMed database using the keywords: 'ketogenic diet in Alzheimer’s disease,' 'ketogenic therapies Alzheimer disease,' and 'ketogenic diet in neurological disease’.
SUMMARY:
The ketogenic diet enhances the daily functioning of Alzheimer's patients. It significantly improves their cognitive functions, and changes in brain blood flow are visible in imaging studies. The ketogenic diet also positively modulates the gut microbiome in Alzheimer's patients. It represents a promising option in combating cognitive symptoms of Alzheimer's disease.
References
Harvey P.D.: Domains of cognition and their assessment. Dialogues Clin. Neurosci., 2019; 21 (3): 227-237
National Institute for Health and Care Excellence. NG97. Dementia: assessment, management and support for people living with dementia and their carers: NICE. London 2018; www.nice.org.uk/guidance/ng97 (accesss: 02.12.2023)
Puchalska P, Crawford PA (2017) Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab 25: 262-284
Hui S, Cowan AJ, Zeng X, Yang L, TeSlaa T, Li X, Bartman C, Zhang Z, Jang C, Wang L, Lu W, Rojas J, Baur J, Rabinowitz JD (2020) Quantita-tive Fluxomics of Circulating Metabolites. Cell Metab 32: 1-13
Włodarek D (2019) Role of Ketogenic Diets in Neurodegenerative Di-seases (Alzheimer’s Disease and Parkinson’s Disease). Nutrients 11: 1-11
Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ (2019) Ketogenic Diet in Alzheimer’s Disease. Int J Mol Sci 20: 1-19
Gupta L, Khandelwal D, Kalra S, Gupta P, Dutta D, Aggarwal S (2017) Ketogenic diet in endocrine disorders: Current perspectives. J Post-grad Med 63: 242-251
Yang H, Shan W, Zhu F, Wu J, Wang Q (2019) Ketone Bodies in Neu-rological Diseases: Focus on Neuroprotection and Underlying Mecha-nisms. Front Neurol 10: 1-11
Newman JC, Verdin E (2014) Ketone bodies as signaling metabolites. Trends Endocrinol Metab 25: 42-52
McDonald TJW, Cervenka MC (2017) Ketogenic Diets for Adults With Highly Refractory Epilepsy. Epilepsy Curr 17: 346-350
Lilamand M, Mouton-Liger F, Di Valentin E, Sànchez Ortiz M and Paquet C (2022) Efficacy and Safety of Ketone Supplementation or Ketogenic Diets for Alzheimer’s Disease: A Mini Review. Front. Nutr. 8:807970. doi: 10.3389/fnut.2021.807970
Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. (2015) 16:358–72. doi: 10.1038/nrn3880
Taylor MK, Sullivan DK, Morris JK, Vidoni ED, Honea RA, Mahnken JD, et al. High glycemic diet is related to brain amyloid accumulation over one year in preclinical Alzheimer’s disease. Front Nutr. (2021) 27:741534. doi: 10.3389/fnut.2021.741534 eCollection 2021.
Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama Study. Neurology. (2010) 75:764–70. doi: 10.1212/WNL.0b013e3181eee25f
Li X, Song D, Leng SX. Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment. Clin Interv Aging. (2015) 10:549–60. eCollection 2015. doi: 10.2147/CIA.S74042
Cunnane SC, Courchesne-Loyer A, Vandenberghe C, St-Pierre V, Fortier M, Hennebelle M, et al. Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer’s disease. Front Mol Neurosci. (2016) 9:53. doi: 10.3389/fnmol.2016.00053
Nare Torosyan, Chakmeedaj Sethanandha, Joshua D. Grill, Michelle L. Dilley, Jooyeon Lee, Jeffrey L. Cummings, Celine Ossinalde, Daniel H. Silverman, Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study, Experimental Gerontology, Volume 111, 2018, Pages 118-121, ISSN 0531-5565, https://doi.org/10.1016/j.exger.2018.07.009.
Phillips, M.C.L., Deprez, L.M., Mortimer, G.M.N. et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alz Res Therapy 13, 51 (2021). https://doi.org/10.1186/s13195-021-00783-x
Fortier, M, Castellano, C-A, St-Pierre, V, et al. A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT. Alzheimer's Dement. 2021; 17: 543–552. https://doi.org/10.1002/alz.12206
Miho Ota, Junko Matsuo, Ikki Ishida, Harumasa Takano, Yuma Yokoi, Hiroaki Hori, Sumiko Yoshida, Kinya Ashida, Kentaro Nakamura, Takeshi Takahashi, Hiroshi Kunugi, Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease, Neuroscience Letters, Volume 690, 2019, Pages 232-236, ISSN 0304-3940, https://doi.org/10.1016/j.neulet.2018.10.048
Ota, M., Matsuo, J., Ishida, I. et al. Effect of a ketogenic meal on cognitive function in elderly adults: potential for cognitive enhancement. Psychopharmacology 233, 3797–3802 (2016). https://doi.org/10.1007/s00213-016-4414-7
Matthew K. Taylor, Debra K. Sullivan, Jonathan D. Mahnken, Jeffrey M. Burns, Russell H. Swerdlow, Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer's disease, Alzheimer's & Dementia: Translational Research & Clinical Interventions, Volume 4, 2018, Pages 28-36, ISSN 2352-8737, https://doi.org/10.1016/j.trci.2017.11.002.
Ravinder Nagpal, Bryan J. Neth, Shaohua Wang, Suzanne Craft, Hariom Yadav, Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment, Nagpal, Ravinder et al. eBioMedicine, Volume 47, 529 – 542, 2019, https://doi.org/10.1016/j.ebiom.2019.08.032
Susan Price, Todd M. Ruppar, Ketogenic therapies in Parkinson's disease, Alzheimer's disease, and mild cognitive impairment: An integrative review, Applied Nursing Research, Volume 74, 2023, 151745, ISSN 0897-1897, https://doi.org/10.1016/j.apnr.2023.151745.
Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. A randomized trial of classical and medium chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009;50:1109–17
Włodarek D (2019) Role of Ketogenic Diets in Neurodegenerative Di-seases (Alzheimer’s Disease and Parkinson’s Disease). Nutrients 11: 1-11
Paoli A, Bosco G, Camporesi EM, Mangar D (2015) Ketosis, ketogenic diet and food intake control: a complex relationship. Front Psychol 6: 1-9
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Julia Samborska, Paweł Więckowiak, Karina Stelmaszak, Katarzyna Stencel, Aleksandra Ogiegło-Kowalczyk, Monika Wojtasik, Michał Głodzik, Marek Miśkiewicz, Katarzyna Żak, Martyna Łęcka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 316
Number of citations: 0
